Weight Loss Drug Recalled—Suspected Tampering
Details of the Alli Recall
USA Today reports that GlaxoSmithKline (GSK) recently announced a retail-level recall of all supplies of Alli due to suspected tampering. GSK says it was alerted to the potential tampering after consumers in seven different states made inquiries into bottles of Alli that contained other tablets. Consumers are asked to verify that supplies of the product are authentic before use.
GSK has launched an investigation into the suspected tampering and is participating with the Food and Drug Administration (FDA) in the recall.
Description of Alli
Alli is a non-prescription version of the weight-loss drug orlistat that works by blocking up to 25% of fat from being absorbed by the intestines.
Authentic Alli tablets:
- Are a turquoise blue capsule with a dark blue band printed with the text “60 Orlistat”
- Come packaged in a labeled bottle that has an inner foil seal imprinted with the words, “Sealed For Your Protection”
Consumers who suspect tampering are asked to notify GSK.
Drug Recall Statistics
According to an ABC News report, drug recalls are issued approximately once a month in the United States. The report cites a study of FDA recalls between 2004 and 2011 and found:
- 1,734 drug recalls were performed in that 7-year time span.
- Of that number, 91 of the recalls were Class I. Class I recalls mean the “greatest likelihood to cause patients serious harm, even death.”